First overseas Joint Venture Company – PathoKBP Innovations LLC (Mongolia)
Pathomics Health is pleased to announce that our first overseas Joint Venture Company – PathoKBP Innovations LLC (Mongolia) has signed a Memorandum of Understanding (MOU) with Fourth Hospital (prestigious private hospital in Mongolia), a significant step toward advancing preventive healthcare solutions and clinical diagnostics. This partnership reflects a mutual commitment toward improving Mongolia healthcare to better […]
Launch of DNLite-DKD test in Singapore
Currently, urine Albuminuria-to-Creatinine Ratio (UACR) and estimation of GFR (eGFR) does not have the sensitivity and specificity for early prediction of diabetic kidney disease(DKD) in type 2 diabetic patient (T2DP). Thus, both UACR and eGFR are unfit for DKD management. Taken from: Nonalbuminuric vs albuminuric diabetic kidney disease in type 2 diabetes: A systematic review […]
Renewal of MOH License for Clinical Laboratory in Singapore
Pathomics Health is pleased to announce the successful renewal of its Ministry of Health license in Singapore, a key milestone in maintaining its commitment to high-quality medical testing and services. This renewal underscores the laboratory’s adherence to stringent health and safety regulations and its ongoing dedication to delivering reliable and accurate diagnostic results. This Ministry […]
Empowering a Healthier Future through Collaboration between Pathomics Health & AGTC Genomics
We are thrilled to announce a groundbreaking Memorandum of Understanding (MoU) between AGTC Genomics and Pathomics Health to enhance the accessibility and affordability of precision medicine in Malaysia and Southeast Asia.In an era of advancing medical breakthroughs, we stand at the forefront of a transformative partnership that holds the promise of reshaping healthcare as we […]
Pathomics Health Attains CAP Accreditation in Singapore
Pathomics Health is proud to announce that Pathomics Health Laboratory in Singapore has been accredited by the College of America Pathologists (CAP). This accreditation is a testament to Pathomics Health’s commitment to excellence in healthcare and dedication to providing our patients with the highest quality of care. We are grateful to the team for their […]
Launch of Clinical Laboratory Services in Singapore
Pathomics Health is pleased to introduce the following new tests effective 03 January 2023: EarlyCDT®-Lung QuantiFERON®-TB Gold Plus cPass™ SARS-CoV-2 Neutralization Antibodies Contact us at 6518 9233 or services@pathomicshealth.com for more information.
Clinical Laboratory Obtains MOH License in Singapore
Pathomics Health is licensed by the Singapore Ministry of Health (MOH) under the Healthcare Services Act for clinical diagnostics in the following discipline: Immunology Molecular Microbiology
Collaboration with MAHSA Health
Pathomics Health, an organization with a mission to provide accessible advanced clinical diagnostics, has signed a Memorandum of Understanding (MoU) with MAHSA Health to set up a Joint Centre for Research and Diagnostics Services for Precision Wellness and Clinical Research at MAHSA Avenue. The collaboration focuses on health and wellness screening with MAHSA Health to […]
Pacific Insurance Collaboration
MiCare Collaboration
Pathomics Health has announced a collaboration with MiCare, a regional Third-Party Administrator (TPA) that helps insurers, corporations, organizations, and individuals better manage healthcare costs and enhance member health through innovative digital solutions. Through this collaboration, MiCare’s clients will have access to the complete suite of healthcare services from Pathomics Health, including: Predictive genetic test report […]